KEY TOPICS OF DISCUSSION
Big-Pharma training with Biotech mentality to “Accelerate Molecules to Medicines”
• Solving complicated CMC problems for NCEs using “First Time Right” basis, for FIH
• Minimising timelines in comparison to other CDMOs and utilising the dynamics of cost structures
• Examining global resources and addressing the transparency in IP protection
Dr. Chris H. Senanayake, Ph.D. CSO, TCG Lifesciences Pvt. Ltd. / CEO & CSO, TCG GreenChem, Inc (NJ & VA, USA)
Dr. Joseph D. Armstrong, III, Ph.D. COO, TCG GreenChem, Inc (NJ & VA, USA)
Continue topic – Big Pharma training with Biotech mentality to “Accelerate Molecules to Medicines”
• Accelerating innovative technologies embedded in Process Research and Development for API
• Partnership approaches:
1. Smooth tech transfer for API within global setting
2. Discussing the advantages of English speaking scientists, scientific project managers andengagements with client-based approaches
3. Project management is from US operations and 24 hour delivery in problem solving
Dr. Subho Roy, Ph.D, Vice President – Business Head, Clinivent Research Pvt. Ltd, A 100% subsidiary of TCG Lifesciences
Dr. Chris H. Senanayake, Ph.D, CSO, TCG Lifesciences Pvt. Ltd. / CEO & CSO, TCG GreenChem, Inc
(NJ & VA, USA)
Dr. Joseph D. Armstrong, III, Ph.D, COO, TCG GreenChem, Inc (NJ & VA, USA)
Dr. Gopal Sirasani, Director, CDMO Business Development and Technical Operations, TCG GreenChem
WHY BOOK YOUR VIP SEAT NOW?
You will be amongst 10-15 Industry thought leaders from a mix of large Pharmaceutical Institutions ensuring you are given ample opportunity to raise questions and contribute from a strategic perspective. You can wine, dine and network with industry leaders who face common challenges in 60-minute roundtable discussions that enable you to share ideas and lessons learned. The dinner will be facilitated by expert moderators, these sessions provide a valuable dialogue with peers on current challenges and topical issues. There is no media, marketing or press, just pure and honest discussion to help solve your key strategic challenges for the next 3-9 months.
Meet the Facilitators
The Dinner will be lead by our expert facilitators
Dr. Sanjoy Kumar Mahanty, Ph.DVice President, Head of Business Development TCG Lifesciences Pvt. Ltd
Dr. Subho Roy, Ph.DVice President – Business Head Clinivent Research Pvt. Ltd, A 100% subsidiary of TCG Lifesciences
Dr. Chris H. Senanayake, Ph.DCSO & CEO TCG Lifesciences Pvt. Ltd. – TCG GreenChem, Inc (NJ & VA, USA)
Dr. Joseph D. Armstrong, III, Ph.DCOO TCG GreenChem, Inc (NJ & VA, USA)
Dr. Gopal Sirasani, Ph.DAssociate Vice President TCG GreenChem, Inc.
More about TCG Lifesciences
At TCG, we address these needs with a proven strategy utilizing the following inherent strengths: Top tier and experienced people from big-Pharma , High end technology platforms and science, like continuous chemistry, catalysis , Large PRD group working across the globe , Operational synergies amongst group companies , Trust-based client relations and depth of engagement spanning two decades and World class facilities and infrastructure. We deliver integrated end-to-end solutions to the global life sciences’ industries.